Trastuzumab rezetecan, CAS [[2924909-11-3]]

Produktübersicht

• Artikelname: Trastuzumab rezetecan, CAS [[2924909-11-3]]
• Artikelnummer: MCE-HY-164762
• Hersteller Artikelnummer: HY-164762
• Alternativnummer: MCE-HY-164762-10MG,MCE-HY-164762-1MG,MCE-HY-164762-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: SHR-A1811

Produktbeschreibung

Trastuzumab rezetecan (SHR-A1811) is a HER2-targeting antibody-drug conjugate (ADC). Trastuzumab rezetecan is composed of a humanized anti-HER2 antibody (HY-P9907), a cleavable linker MC-Gly-Gly-Phe-Gly (HY-44246), and a topoisomerase I inhibitor payload Rezetecan (HY-147408). Trastuzumab rezetecan can be used for research in HER2-positive breast cancer[1].

Produkteigenschaften

• Reinheit: 98.61
• CAS Nummer: [2924909-11-3]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs),EGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: ADC Related